Perfuze Receives the US FDA’s 510(k) Clearance for Novel Neurovascular Aspiration and Access Catheters for the Treatment of Strokes
Shots:
- Perfuze receives the US FDA’s 510(k) clearance for the Millipede 070 Aspiration Catheter & for the 2nd generation of the Millipede 088 Access Catheter
- The Millipede 070 Aspiration Catheter is designed to remove clots rapidly & safely thereby allowing procedural efficiency in restoring blood flow to the brain during endovascular thrombectomy procedures. Additionally, the company is currently enrolling patients in the (MARRS) pivotal clinical evaluation of the Aspiration Catheter, based on which regulatory submissions are expected
- Perfuze’s 2nd generation Millipede 088 Access Catheter allows a safe insertion & guidance of microcatheters for neurointerventional or diagnostic procedures that earlier received the 510(k) clearance in 2022
Ref: Businesswire | Image: Perfuze
Related News:- Ultromics’ EchoGo Amyloidosis Receives the US FDA’s Breakthrough Device Designation to Detect Cardiac Amyloidosis
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Kritika is a content writer at PharmaShots. She is interested in covering recent innovations from the pharma & MedTech industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
